Local Institution

Santa Maria, California 93454

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myeloid Leukemia, Leukemia, Philadelphia-Positive Myeloid Leukemia

Studies at this site

• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early